Cargando…

An analysis of the gene interaction networks identifying the role of PARP1 in metastasis of non-small cell lung cancer

BACKGROUND AND OBJECTIVE: Though there were many researches about the effects of cancer cells on non-small cell lung cancer (NSCLC) currently, it has been rarely reported completed oncogene and its mechanism in tumors by far. Here, we used biological methods with known oncogene of NSCLC to find new...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Kai, Li, Yajie, Xu, Hui, Zhang, Chunfeng, Li, Zhiqiang, Wang, Wei, Wang, Baofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675631/ https://www.ncbi.nlm.nih.gov/pubmed/29152079 http://dx.doi.org/10.18632/oncotarget.20256

Ejemplares similares

Role of PARP1-mediated autophagy in EGFR-TKI resistance in non-small cell lung cancer
por: Zhang, Zhimin, et al.
Publicado: (2020)

PARP-1 genetic polymorphism associated with radiation sensitivity of non-small cell lung cancer
por: Wang, Hetong, et al.
Publicado: (2022)

MTA1-TJP1 interaction and its involvement in non-small cell lung cancer metastasis
por: Wang, Wei, et al.
Publicado: (2022)

Mapping the Genetic Interaction Network of PARP inhibitor Response
por: Simpson, Danny, et al.
Publicado: (2023)

Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
por: Zuo, Hao, et al.
Publicado: (2020)

The disappearance of gastric metastasis and liver metastasis in non-small cell lung adenocarcinoma is due to osimertinib
por: Wang, Yun, et al.
Publicado: (2023)

Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer
por: Juncheng, Pan, et al.
Publicado: (2022)

Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes
por: Jin, Jing, et al.
Publicado: (2020)

PARP1 inhibition elicits immune responses against non-small cell lung cancer
por: Juncheng, Pan, et al.
Publicado: (2022)

Rare giant ovarian metastasis arising from a small primary lung adenocarcinoma: a case report
por: Wang, Baofeng, et al.
Publicado: (2023)

MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN
por: Wang, Hongyan, et al.
Publicado: (2015)

Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes
por: Maluchenko, Natalya, et al.
Publicado: (2022)

A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway
por: Lu, Yu, et al.
Publicado: (2021)

Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis
por: Lu, Hui, et al.
Publicado: (2021)

Target engagement imaging of PARP inhibitors in small-cell lung cancer
por: Carney, Brandon, et al.
Publicado: (2018)

CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
por: Zhao, Hui, et al.
Publicado: (2016)

PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin
por: Apopa, Patrick L., et al.
Publicado: (2018)

Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells
por: Dominici, Claudia, et al.
Publicado: (2021)

Functional analysis of microRNA and transcription factor synergistic regulatory network based on identifying regulatory motifs in non-small cell lung cancer
por: Li, Kening, et al.
Publicado: (2013)

Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer
por: Li, Qing, et al.
Publicado: (2022)

PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve Responses
por: Knelson, Erik H., et al.
Publicado: (2021)

STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in non-small cell lung cancer
por: Ma, Zhiqiang, et al.
Publicado: (2019)

HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
por: Ma, Hanlin, et al.
Publicado: (2022)

Annexin 1–nuclear factor‐κB–microRNA‐26a regulatory pathway in the metastasis of non‐small cell lung cancer
por: Guan, Xiaoying, et al.
Publicado: (2019)

Stomatin plays a suppressor role in non-small cell lung cancer metastasis
por: An, Huaying, et al.
Publicado: (2019)

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
por: Li, Shuangying, et al.
Publicado: (2022)

Bilateral Choroidal Metastasis from Non-Small Cell Lung Cancer
por: Namad, Tariq, et al.
Publicado: (2014)

The Efficacy and Safety of Afatinib in Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Meta-Analysis
por: Jin, Hui, et al.
Publicado: (2023)

MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4
por: Li, Hui, et al.
Publicado: (2016)

CEP20 promotes invasion and metastasis of non-small cell lung cancer cells by depolymerizing microtubules
por: Feng, Sijie, et al.
Publicado: (2023)

Complementary CRISPR genome-wide genetic screens in PARP10-knockout and overexpressing cells identify synthetic interactions for PARP10-mediated cellular survival
por: Khatib, Jude B., et al.
Publicado: (2022)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
por: Yélamos, José, et al.
Publicado: (2020)

A real-world study in advanced non-small cell lung cancer with de novo brain metastasis
por: Lei, Lei, et al.
Publicado: (2021)

PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches
por: Barayan, Ranya, et al.
Publicado: (2020)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells
por: Zhao, Yahui, et al.
Publicado: (2021)

Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer
por: Ma, Zijian, et al.
Publicado: (2021)

Plasma D-Dimer Level Correlates with Age, Metastasis, Recurrence, Tumor-Node-Metastasis Classification (TNM), and Treatment of Non-Small-Cell Lung Cancer (NSCLC) Patients
por: Guo, Jiqiang, et al.
Publicado: (2021)

DDX24 promotes metastasis by regulating RPL5 in non‐small cell lung cancer
por: Hu, Xinyan, et al.
Publicado: (2022)

Transgelin interacts with PARP1 in human colon cancer cells
por: Lew, Zhen-xian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b767kbt3tgdoik6rq1s1updse4